Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07605416
What this trial is testing

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Who this might be right for
Plasma Cell Leukemia
National Cancer Institute (NCI) 74
Early research (Phase 1)Ended earlyNCT03582033
What this trial is testing

A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 83
Testing effectiveness (Phase 2)Study completedNCT01703104
What this trial is testing

The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

Who this might be right for
Sickle Cell Anemia
Lagos State University 150
Not applicableUnknownNCT04280133
What this trial is testing

CAR T-CELL Therapy Educational Video Trial

Who this might be right for
Hematologic MalignancyCAR-T Cell Therapy
Massachusetts General Hospital 80
Early research (Phase 1)Study completedNCT00693433
What this trial is testing

Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT02519452
What this trial is testing

Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)Study completedNCT00176852
What this trial is testing

Stem Cell Transplant for Hemoglobinopathy

Who this might be right for
Sickle Cell DiseaseThalassemiaSevere Congenital Neutropenia+2 more
Masonic Cancer Center, University of Minnesota 22
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT01744665
What this trial is testing

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

Who this might be right for
CML
Novartis Pharmaceuticals 59
Not applicableLooking for participantsNCT06713811
What this trial is testing

Evaluation of the Impact of Electronic Monitoring on Patient Compliance in Hematology

Who this might be right for
Hemopathies
Private Hospital of Confluent, France 110
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Study completedNCT01716793
What this trial is testing

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Myelocytic, Acute
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 354
Testing effectiveness (Phase 2)Looking for participantsNCT05745714
What this trial is testing

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Not applicableNot Yet RecruitingNCT07761104
What this trial is testing

Phenotyping Acute Non-Severe Anemia in the Emergency Department

Who this might be right for
Anemia
Hospices Civils de Lyon 59
Early research (Phase 1)WithdrawnNCT02640833
What this trial is testing

Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin Lymphoma
AbbVie
Testing effectiveness (Phase 2)Study completedNCT04906447
What this trial is testing

Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

Who this might be right for
Sickle Cell Disease
University of Illinois at Chicago 379
Large-scale testing (Phase 3)Study completedNCT03350347
What this trial is testing

Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 164
Testing effectiveness (Phase 2)Study completedNCT02556099
What this trial is testing

EXTEND EXpanding Treatment for Existing Neurological Disease

Who this might be right for
Sickle Cell Anemia
Children's Hospital Medical Center, Cincinnati 43
Not applicableStudy completedNCT00899899
What this trial is testing

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

Who this might be right for
Leukemia
Children's Oncology Group 135
Large-scale testing (Phase 3)Study completedNCT00090493
What this trial is testing

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 4
Next Page
26